AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Cipremi Injection

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Remdesivir (100mg)

Overview Cipremi Injection

Remdesivir injection is a wide-ranging antiviral medication indicated for hospitalized adults and children with severe, confirmed or suspected COVID-19. This treatment reduces viral levels, accelerating recovery. Its mechanism involves inhibiting RNA-dependent RNA polymerase, a vital enzyme for SARS-CoV-2 replication. Administered intravenously under medical supervision, Remdesivir requires a physician's prescription, adhering strictly to the prescribed dosage and duration. Self-medication is strictly prohibited. Common adverse events include anemia, pyrexia, acute kidney impairment, hyperglycemia, and elevated liver enzymes. Report any allergic reaction or concerning side effect immediately to your doctor. Disclose pregnancy or breastfeeding status to your physician. Caution is advised when administering to elderly or pediatric patients.

Uses of Cipremi Injection

Managing the infection caused by the SARS-CoV-2 virus

Major Benefits of Cipremi Injection:

Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Cipremi Injection:

  • Headache
  • Rash
  • Extravasation
  • Increased prothrombin time
  • Increased transaminase level in blood

How to use Cipremi Injection:

Administering this medication will be handled by your physician or their assistant; self-medication is strongly discouraged.

How Cipremi Injection works:

Cipremi Injection is a wide-ranging antiviral medication. Its mechanism of action involves blocking RNA polymerase, an RNA-dependent enzyme crucial for SARS-CoV-2 replication. This inhibition reduces the viral burden within the patient.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Cipremi Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Employing Cipremi Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Cipremi Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Cipremi Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if you exhibit any symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Cipremi Injection's use in individuals with renal impairment. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Cipremi Injection's use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Cipremi Injection :

NA

Facts to Know About Cipremi Injection

LabelValue
Chemical Type Amino acid alkyl esters
Developing Habits No.
Type of Therapy Antimicrobials

FAQs on Cipremi Injection

COVID-19, caused by the novel SARS-CoV-2 virus, is a highly contagious respiratory illness. This newly emerged virus primarily affects the lungs, causing symptoms such as fever, cough, and shortness of breath.
Cipremi Injection, an antiviral medication, has demonstrated effectiveness in managing severe COVID-19 in hospitalized patients during laboratory studies. While not yet approved for COVID-19 treatment, these studies suggest potentially faster recovery times compared to alternative treatments. However, the safety and efficacy of Cipremi Injection for COVID-19 remain under investigation in ongoing clinical trials.
The Food and Drug Administration (FDA), under the authority of the Food, Drug, and Cosmetic Act, issues Emergency Use Authorizations (EUAs) for medical products—including medicines, vaccines, and diagnostic devices—to combat serious public health threats like COVID-19. An EUA allows use of a product before full FDA approval, balancing potential benefits against known risks.
Cipremi Injection is administered intravenously by a doctor only to hospitalized children and adults with severe COVID-19. Severe COVID-19 is defined as SpO2 ≤94% on room air or requiring supplemental oxygen, mechanical ventilation, or ECMO. Self-administration is strictly prohibited. Adhere closely to your doctor's instructions for optimal results.
The EU has authorized Cipremi Injection for hospitalized patients with suspected or confirmed severe COVID-19, demonstrating faster recovery from serious breathing problems in both adult and pediatric populations.
Ongoing clinical trials are evaluating Cipremi Injection's ability to inhibit SARS-CoV-2 replication, thus reducing viral load and potentially accelerating recovery from COVID-19.
Cipremi Injection may cause anemia, fever, kidney damage, nausea, vomiting, chills, sweating, low blood pressure, and elevated liver enzymes. However, this is not an exhaustive list of potential side effects, and further research is needed. The use of Cipremi Injection in treating COVID-19 is under investigation, and additional risks may exist.
Insufficient data exists to confirm the safety and efficacy of Cipremi Injection for treating hospitalized adults and children with severe COVID-19. Its use in this population is permitted only after careful risk-benefit assessment. Ongoing clinical trials are evaluating its safety, which remains unestablished.
Limited data exists on Cipremi Injection's use in treating COVID-19. Its safety and effectiveness in pregnant or breastfeeding individuals are unknown. If you are pregnant, breastfeeding, or planning pregnancy, and test positive or are suspected of having COVID-19, consult your doctor. They will determine the best course of treatment for your individual circumstances.
Inform your doctor of all your medical conditions, including kidney or liver problems, serious illnesses like heart disease or diabetes, and any allergies before receiving Cipremi Injection. Disclose all medications you're taking—prescription, over-the-counter, vitamins, or herbal products—as Cipremi Injection may interact with them. Specifically mention if you use medications containing chloroquine phosphate or hydroxychloroquine sulfate. Also, tell your doctor if you are pregnant, plan to conceive, or are breastfeeding.
Cipremi Injection is not indicated for Covid-19 prevention; its efficacy in this context is unsupported by data.
The Drug Controller General of India (DCGI) has granted emergency use authorization for Cipremi Injection during the pandemic. Its use is restricted to confirmed COVID-19 patients with clinical indication and is not for preventative purposes or suspected cases.
Cipremi Injection
3,456
MRP 4,000
13% off